RegentAtlantic Capital’s ResMed RMD Stock Holding History

RegentAtlantic Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$324K	Sell	1,483 -96	-6%	-$21.9K	0.01%	547
2022 Q2	$331K	Buy	1,579 +496	+46%	+$106K	0.01%	531
2022 Q1	$263K	Sell	1,083 -27	-2%	-$6.53K	0.01%	601
2021 Q4	$289K	Sell	1,110 -565	-34%	-$147K	0.01%	581
2021 Q3	$441K	Buy	1,675 +656	+64%	+$179K	0.01%	464
2021 Q2	$251K	Buy	+1,019	New	+$214K	0.01%	572
2015 Q1	–	Sell	-425	Closed	-$23.8K	–	813
2014 Q4	$23.8K	Buy	+425	New	+$22.2K	﹤0.01%	728

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

RegentAtlantic Capital's RMD Position: Q3 2022 in Review

RegentAtlantic Capital reduced its ResMed (RMD) stake by 6.1% in Q3 2022, selling an estimated $21.9K and leaving 1,483 shares worth $324K. The position accounts for 0.01% of the portfolio, ranked #547.

RegentAtlantic Capital first reported a position in RMD in Q4 2014 and has held it in 7 quarters since. The position peaked at $441K in Q3 2021. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

RegentAtlantic Capital held 1,483 shares of ResMed worth $324K as of Q3 2022.
RegentAtlantic Capital sold 96 ResMed shares in Q3 2022, an estimated $21.9K.
ResMed made up 0.01% of RegentAtlantic Capital's portfolio in Q3 2022, its #547 holding.
RegentAtlantic Capital first reported a position in ResMed in Q4 2014 and has held it in 7 quarters since.
RegentAtlantic Capital's ResMed position peaked at $441K in Q3 2021.
667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.